IP Suit Over Amylin Drug Promos Timely, Justices Told
Consumer Health Information Corp. has asked the U.S. Supreme Court to revive its copyright infringement suit against Amylin Pharmaceuticals Inc. over patient education materials Consumer Health produced for the diabetes drug...To view the full article, register now.
Already a subscriber? Click here to view full article